Cargando…
Myxobacteria: natural pharmaceutical factories
Myxobacteria are amongst the top producers of natural products. The diversity and unique structural properties of their secondary metabolites is what make these social microbes highly attractive for drug discovery. Screening of products derived from these bacteria has revealed a puzzling amount of h...
Autores principales: | Diez, Juana, Martinez, Javier P, Mestres, Jordi, Sasse, Florenz, Frank, Ronald, Meyerhans, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420326/ https://www.ncbi.nlm.nih.gov/pubmed/22545867 http://dx.doi.org/10.1186/1475-2859-11-52 |
Ejemplares similares
-
Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay
por: Martinez, Javier P, et al.
Publicado: (2013) -
The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway
por: Fleta-Soriano, Eric, et al.
Publicado: (2014) -
Investigations on the mode of action of gephyronic acid, an inhibitor of eukaryotic protein translation from myxobacteria
por: Muthukumar, Yazh, et al.
Publicado: (2018) -
Are Myxobacteria intelligent?
por: Kaiser, Dale
Publicado: (2013) -
Myxobacteria: Moving, Killing, Feeding, and Surviving Together
por: Muñoz-Dorado, José, et al.
Publicado: (2016)